DIA
GSK icon

Davidson Investment Advisors’s GSK GSK Stock Holding History

Davidson Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-304
Closed -$14K – 212
2016
Q4 		$14K Hold
304
– – ﹤0.01% 185
2016
Q3 		$16K Hold
304
– – ﹤0.01% 170
2016
Q2 		$16K Hold
304
– – ﹤0.01% 170
2016
Q1 		$15K Buy
+304
New +$15.1K ﹤0.01% 194

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Davidson Investment Advisors's GSK Position: Q1 2017 in Review

Davidson Investment Advisors sold out of GSK (GSK) in Q1 2017, closing a stake of 304 shares — an estimated $14K sold.

Davidson Investment Advisors first reported a position in GSK in Q1 2016 and held it in 4 quarters. The position peaked at $16K in Q3 2016. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

  • Davidson Investment Advisors reported no remaining GSK position as of Q1 2017 after selling out during the quarter.
  • Davidson Investment Advisors sold 304 GSK shares in Q1 2017, an estimated $14K.
  • Davidson Investment Advisors first reported a position in GSK in Q1 2016 and held it in 4 quarters.
  • Davidson Investment Advisors's GSK position peaked at $16K in Q3 2016.
  • 786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Davidson Investment Advisors's 13F filing for Q1 2017, filed 12 May 2017.